Treximet Tablet, Film Coated
Product Images NDC 42847-850

5 FDA label images from Currax Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Treximet (NDC 42847-850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Currax Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Treximet 01)

Chemical Structure (Treximet 01)
Chemical structure of Sumatriptan Succinate and Naproxen Sodium, the active ingredients in Treximet. The structure shows distinct molecular groups including a sulfonamide-containing benzene ring and a carboxyl group, representing the combined salt form used in the medication.*
FDA Label Image

Chemical Structure (Treximet 02)

Chemical Structure (Treximet 02)
Chemical structure of Naproxen Sodium, one of the active ingredients in Treximet, comprising aromatic rings with methoxy and carboxylate sodium groups.*
FDA Label Image

Figure 1 (Treximet 03)

Figure 1 (Treximet 03)
A line graph depicting the percentage of patients with relief over time (hours postdose) comparing Treximet 85/500 mg, Sumatriptan 85 mg, Naproxen Sodium 500 mg, and placebo. The graph shows increasing patient relief percentages up to 2 hours postdose for each treatment group, with Treximet showing the highest percentage of relief.*
FDA Label Image

Figure 2 (Treximet 04)

Figure 2 (Treximet 04)
A line graph comparing the percentage of patients taking rescue medication over 24 hours postdose. The graph shows four lines representing Placebo, Naproxen, Sumatriptan, and TREXIMET 85/500 mg, with Placebo having the highest percentage and TREXIMET the lowest, indicating patient medication use over time.*
FDA Label Image

Principal Display Panel (9 Tablet Bottle Label)

Principal Display Panel (9 Tablet Bottle Label)
Label for Treximet 85 mg/500 mg tablets, film coated oral tablets containing sumatriptan succinate and naproxen sodium. The label includes dosage strength, warnings not to repack or chew tablets, and storage instructions. Distributed by Currax Pharmaceuticals LLC, Brentwood, TN. Package contains 9 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.